Bone Marrow Karyotyping

Hematological cancers are heterogenous with regard to morphology, immunophenotype and genetic rearrangements. Conventional cytogenetic analysis, which identifies multiple recurrent chromosomal aberrations, is widely recognized as one of the most important diagnostic and prognostic determinants in these patients.